NewAmsterdam Pharma Company NV (NAMS)
Aktien-Chart
Loading...
•
Kauf
•
Verkauf
•
Geplanter Kauf
•
Geplanter Verkauf
Netto-Kauf
Netto-Verkauf
Earnings
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | 2025-03-26 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
1.135
+0.0%
22,4925.521 USD |
1.135 +0.0% | 22,49 | 25.521 USD | |
| 2025-03-06 | 2025-03-04 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
4.005
+0.1%
21,0284.203 USD |
4.005 +0.1% | 21,02 | 84.203 USD | |
| 2025-03-05 | 2025-03-04 | V Verkauf |
Chief Accounting Officer Führungsperson |
150.000
-90.9%
20,373.055.500 USD |
150.000 -90.9% | 20,37 | 3.055.500 USD | |
| 2025-01-02 | 2024-12-30 | GV Geplanter Verkauf | Large shareholder |
29.846
-0.3%
25,54762.174 USD |
29.846 -0.3% | 25,54 | 762.174 USD | |
| 2024-12-30 | 2024-12-27 | GV Geplanter Verkauf | Large shareholder |
41.472
-0.4%
25,951.076.290 USD |
41.472 -0.4% | 25,95 | 1.076.290 USD | |
| 2024-12-30 | 2024-12-26 | GV Geplanter Verkauf | Large shareholder |
33.438
-0.3%
26,01869.629 USD |
33.438 -0.3% | 26,01 | 869.629 USD | |
| 2024-12-26 | 2024-12-24 | GV Geplanter Verkauf | Large shareholder |
16.164
-0.1%
25,66414.831 USD |
16.164 -0.1% | 25,66 | 414.831 USD | |
| 2024-12-26 | 2024-12-23 | GV Geplanter Verkauf | Large shareholder |
25.132
-0.2%
25,49640.625 USD |
25.132 -0.2% | 25,49 | 640.625 USD | |
| 2024-12-26 | 2024-12-20 | GV Geplanter Verkauf | Large shareholder |
5.629
-0.1%
26,13147.071 USD |
5.629 -0.1% | 26,13 | 147.071 USD | |
| 2024-12-26 | 2024-12-20 | GV Geplanter Verkauf | Large shareholder |
44.143
-0.4%
25,531.126.993 USD |
44.143 -0.4% | 25,53 | 1.126.993 USD | |
| 2024-12-20 | 2024-12-19 | GV Geplanter Verkauf | Large shareholder |
56.506
-0.5%
25,451.437.806 USD |
56.506 -0.5% | 25,45 | 1.437.806 USD | |
| 2024-12-20 | 2024-12-18 | GV Geplanter Verkauf | Large shareholder |
46.210
-0.4%
26,551.226.857 USD |
46.210 -0.4% | 26,55 | 1.226.857 USD | |
| 2024-12-20 | 2024-12-18 | GV Geplanter Verkauf | Large shareholder |
54.518
-0.5%
25,721.402.050 USD |
54.518 -0.5% | 25,72 | 1.402.050 USD | |
| 2024-12-18 | 2024-12-17 | GV Geplanter Verkauf | Large shareholder |
47.736
-0.4%
26,451.262.441 USD |
47.736 -0.4% | 26,45 | 1.262.441 USD | |
| 2024-12-18 | 2024-12-17 | GV Geplanter Verkauf | Large shareholder |
66.648
-0.6%
25,601.706.315 USD |
66.648 -0.6% | 25,60 | 1.706.315 USD | |
| 2024-12-18 | 2024-12-16 | GV Geplanter Verkauf | Large shareholder |
1.096
-0.0%
25,0027.400 USD |
1.096 -0.0% | 25,00 | 27.400 USD | |
| 2024-12-16 | 2024-12-13 | GV Geplanter Verkauf | Large shareholder |
25.751
-0.2%
25,01644.048 USD |
25.751 -0.2% | 25,01 | 644.048 USD | |
| 2024-12-16 | 2024-12-12 | GV Geplanter Verkauf | Large shareholder |
25.963
-0.2%
26,18679.615 USD |
25.963 -0.2% | 26,18 | 679.615 USD | |
| 2024-12-16 | 2024-12-12 | GV Geplanter Verkauf | Large shareholder |
140.048
-1.2%
25,253.536.212 USD |
140.048 -1.2% | 25,25 | 3.536.212 USD | |
| 2024-12-12 | 2024-12-11 | GV Geplanter Verkauf | Large shareholder |
4.894
-0.0%
27,11132.671 USD |
4.894 -0.0% | 27,11 | 132.671 USD | |
| 2024-12-12 | 2024-12-11 | GV Geplanter Verkauf | Large shareholder |
18.583
-0.2%
26,41490.684 USD |
18.583 -0.2% | 26,41 | 490.684 USD | |
| 2024-12-12 | 2024-12-11 | GV Geplanter Verkauf | Large shareholder |
130.561
-1.1%
25,263.298.454 USD |
130.561 -1.1% | 25,26 | 3.298.454 USD | |
| 2024-12-12 | 2024-12-10 | GV Geplanter Verkauf | Large shareholder |
48.511
-0.4%
26,151.268.606 USD |
48.511 -0.4% | 26,15 | 1.268.606 USD | |
| 2024-12-12 | 2024-12-10 | GV Geplanter Verkauf | Large shareholder |
259.739
-2.2%
25,226.550.202 USD |
259.739 -2.2% | 25,22 | 6.550.202 USD | |
| 2024-11-19 | 2024-11-18 | GV Geplanter Verkauf | Large shareholder |
33.273
-0.3%
25,08834.440 USD |
33.273 -0.3% | 25,08 | 834.440 USD | |
| 2024-11-19 | 2024-11-15 | GV Geplanter Verkauf | Large shareholder |
8.530
-0.1%
25,02213.436 USD |
8.530 -0.1% | 25,02 | 213.436 USD | |
| 2024-11-15 | 2024-11-14 | GV Geplanter Verkauf | Large shareholder |
9.832
-0.1%
25,01245.856 USD |
9.832 -0.1% | 25,01 | 245.856 USD | |
| 2024-11-15 | 2024-11-13 | GV Geplanter Verkauf | Large shareholder |
1.066
-0.0%
25,0026.655 USD |
1.066 -0.0% | 25,00 | 26.655 USD | |
| 2024-10-01 | 2024-10-01 | V Verkauf |
Chief Accounting Officer Führungsperson |
45.000
-100.0%
15,72707.400 USD |
45.000 -100.0% | 15,72 | 707.400 USD | |
| 2024-09-30 | 2024-09-26 | K Kauf |
Chief Business Officer Führungsperson |
1.104
+inf%
15,7017.333 USD |
1.104 +inf% | 15,70 | 17.333 USD | |
| 2024-08-22 | 2024-08-20 | K Kauf |
Chief Executive Officer Geschäftsführender Verwaltungsratsmitglied |
5.000
+2.4%
16,2781.350 USD |
5.000 +2.4% | 16,27 | 81.350 USD | |
| 2024-06-24 | 2024-06-20 | K Kauf |
Chief Executive Officer Geschäftsführender Verwaltungsratsmitglied |
5.000
+2.5%
17,2686.309 USD |
5.000 +2.5% | 17,26 | 86.309 USD | |
| 2024-03-28 | 2024-03-26 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
8.429
+0.3%
21,50181.224 USD |
8.429 +0.3% | 21,50 | 181.224 USD | |
| 2024-03-27 | 2024-03-26 | V Verkauf |
Kastelein Johannes Jacob Pieter Chief Scientific Officer Geschäftsführender Verwaltungsratsmitglied |
190.476
-100.0%
21,504.095.234 USD |
190.476 -100.0% | 21,50 | 4.095.234 USD | |
| 2024-02-21 | 2024-02-13 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
5.000
+25.2%
19,0095.000 USD |
5.000 +25.2% | 19,00 | 95.000 USD |